Zydus Cadila receives tentative approval from USFDA for Ibrutinib EP News Bureau Jul 22, 2021 The drug will be manufactured at the group’s formulation manufacturing facility at the Special Economic Zone (SEZ), Ahmedabad
NATCO gets tentative US FDA approval for Ibrutinib tablets EP News Bureau Apr 10, 2021 NATCO feels that it is eligible for 180 days of sole generic marketing exclusivity for all the strengths of the tablet dosage form…
